Monoclonal Antibody to Tumor Necrosis Factor α Attenuates Cardiopulmonary Dysfunction in Porcine Gram-negative Sepsis

Archives of Surgery

Volumn 127, Issue 2, 1992, Pages 138-145

  Walsh, Ciaran J ^a   Sugerman, Harvey J ^a   Mullen, Patrick G ^a   Carey, P Declan ^a   Leeper Woodford, Sandra K ^a   Jesmok, Gary J ^b   Ellis, Earl F ^a   Fowler, Alpha A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Miles Cutter Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; HEART FUNCTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; PULMONARY HYPERTENSION; SEPSIS; SWINE;

ANIMAL; ANTIBODIES, MONOCLONAL; BACTEREMIA; EXTRAVASCULAR LUNG WATER; HEMODYNAMICS; LUNG; PSEUDOMONAS INFECTIONS; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SWINE; THROMBOXANE B2; TUMOR NECROSIS FACTOR;

EID: 0026587580     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1992.01420020020003     Document Type: Article

References (32)

1. Parillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med. 1990;113:227-242.
2. Simpson SQ, Casey LC. Role of tumor necrosis factor in sepsis and acute lung injury. Crit Care Clin. 1989;5:27-43.
3. Byrne K, Carey PD, Sugerman HJ. Adult respiratory distress syndrome. Acute Care. 1987;13:206-234.
4. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98:593-597.
5. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990;141:765-788.
6. Jacobs RF, Tabor DR. Immune cellular interactions during sepsis and septic injury. Crit Care Clin. 1989;5:9-26.
7. Michie HR, Guillou PJ, Wilmore DW. Tumour necrosis factor and bacterial sepsis. Br J Surg. 1989;76:670-671.
8. Michie HR, Wilore DW. Sepsis and tumor necrosis factor: bedfellows that cannot be ignored. Ann Surg. 1990;212:653-654.
9. Silva AT, Bayston KF, Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock. J Infect Dis. 1990; 162:421-427.
10. Mathison JC, Wolfson E, Elevitch RJ. Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest. 1988;81:1925-1937.
11. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662-664.
12. Hinshaw LB, Tekamp-Olson P, Chang AC, et al. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNFα). Circ Shock. 1990;30:279-292.
13. Exley AR, Cohen J, Buurman W, et al. Monoclonal antibody to TNF in severe septic shock. Lancet. 1990;335:1275-1277.
14. Lewis FR, Elings VB, Hill S, Christensen TM. The measurement of extravascular lung water by thermal-green dye indicator dilution. Ann NY Acad Sci. 1982;384:394-410.
15. Flock DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984;68:167-175.
16. Ellis EF, Police RJ, Yancey LM, Grabeel MN, Heizer ML, Holt SA. Effect of fish oil n-3 fatty acids on cerebral microcirculation. Am J Physiol. 1990;258:1780-1785.
17. Sánchez-Cantú L, Rode HN, Yun TJ, Christou NV. Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg. 1991;126:231-235.
18. Demling RH, Smith M, Gunther R, et al. Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol. 1981;240:348-353.
19. Lee CC, Sugerman HJ, Tatum JL, et al. Effects of ibuprofen on a pig Pseudomonas ARDS model. J Surg Res. 1986;40:438-444.
20. Johnson J, Meyrick B, Jesmok G, Brigham KL. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol. 1989;66:1448-1454.
21. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA. Interleukin 1 induces a shock-like state of rabbits. J Clin Invest. 1988;81:1162-1172.
22. Van der Meer JWM, Barza M, Wolff SM, Dinarello CA. Low dose recombinant interleukin-1 protects granulocytopenic mice from lethal Gram-negative infection. Proc Natl Acad Sci USA. 1988;85:1620-1623.
23. Evans DA, Jacobs DO, Revhaug A, Wilmore DW. The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg. 1989;209:312-321.
24. Kettlhut IC, Fiers W, Goldberg AL. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci USA. 1987; 84:4273-4277.
25. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
26. Carey PD, Leeper-Woodford SK, Walsh CJ, Byrne K, Fowler AA, Sugerman HJ. Delayed cyclooxygenase blockade reduces the neutrophil respiratory burst and plasma tumor necrosis factor levels in sepsis-induced acute lung injury. J Trauma. 1991;31:733-741.
27. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome: prognosis after onset. Am Rev Respir Dis. 1985;132:472-478.
28. Hall-Angeras M, Angeras U, Zamir O, Hasselgren PO, Fischer JE. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery. 1990;108:460-466.
29. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor (TNF) participates in the regulation of muscle proteolysis during sepsis. Arch Surg. 1992;127:143-150.
30. Hasselgren PO, Talamini MA, LaFrance R, James JH, Peters JC, Fischer JE. Effect of indomethacin on proteolysis in septic muscle. Ann Surg. 1985;202:557-562.
31. Hasselgren PO, Warner BW, Hummel RP, James JH, Ogle C, Fischer JE. Further evidence that accelerated muscle protein breakdown during sepsis is not mediated by prostaglandin E2. Ann Surg. 1988;207:399-403.
32. Hasselgren PO, Zamir O, James JH, Fischer JE. Prostaglandin E2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats. Biochem J. 1990;270:45-50.